Call for Abstracts – Early Bird Deadline: 15 July 2026
13th International Cancer and Medical Oncology Conference and Exhibition
February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE
The global fight against cancer continues to evolve through scientific innovation, multidisciplinary collaboration, and groundbreaking clinical research. The 13th International Cancer and Medical Oncology Conference and Exhibition invites oncologists, cancer researchers, physicians, surgeons, radiologists, pathologists, immunologists, healthcare professionals, academicians, pharmaceutical experts, biotechnology innovators, and students from around the world to submit their latest research findings and join one of the most anticipated international oncology events.
The Early Bird Registration and Abstract Submission Deadline is 15 July 2026. Researchers are encouraged to submit their abstracts early to secure discounted registration, priority review, and the opportunity to present their work before a global audience of leading cancer experts.
Hosted at the prestigious Novotel Al Barsha, Dubai, UAE, on February 1–2, 2027, this international gathering provides an exceptional platform for sharing innovative discoveries, discussing emerging treatment strategies, and establishing valuable collaborations that advance cancer prevention, diagnosis, and patient care.
Why Submit Your Abstract?
Presenting your research at an international conference provides recognition while contributing to global scientific progress.
Participants will have the opportunity to:
Present original research to an international audience.
Receive valuable feedback from renowned oncology experts.
Showcase clinical studies, innovations, and case reports.
Publish research in conference-associated journals.
Build collaborations with researchers and healthcare organizations.
Increase professional visibility.
Expand academic and clinical networks.
Gain recognition through awards and presentation certificates.
Explore industry innovations and emerging technologies.
Contribute to improving cancer diagnosis and treatment worldwide.
Early Bird Registration Benefits
Researchers registering before 15 July 2026 can enjoy several advantages:
Discounted registration fee
Priority abstract evaluation
Guaranteed presentation slot upon acceptance
Access to all keynote and scientific sessions
Networking with international experts
Opportunity to meet industry leaders
Participation certificate
Conference materials
Access to exhibition area
Enhanced international exposure
Conference Highlights
The conference brings together distinguished professionals from:
Medical Oncology
Radiation Oncology
Surgical Oncology
Clinical Oncology
Hematology
Pathology
Precision Medicine
Pharmaceutical Sciences
Cancer Biology
Translational Research
Molecular Oncology
Public Health
Biotechnology
Artificial Intelligence in Oncology
Clinical Trials
Attendees will experience keynote lectures, scientific presentations, panel discussions, poster sessions, industry exhibitions, networking events, and collaborative workshops.
30 CME/CPD Credits
The conference is designed to support continuing professional development by offering approximately 30 CME/CPD Credits, making it an ideal educational opportunity for healthcare professionals seeking to enhance their knowledge while fulfilling professional development requirements.
Benefits include:
Updated evidence-based clinical practices
Exposure to emerging therapies
Improved patient management strategies
International clinical perspectives
Continuing education recognition
Professional credential enhancement
Scientific Tracks
The conference covers a broad spectrum of oncology and cancer research, including:
Cancer Biology
Medical Oncology
Immunotherapy
Radiotherapy
Chemotherapy
Surgical Oncology
Hormone Therapy
Leukemia
Cancer Genetics
Cancer Epigenetics
Tumor Microenvironment
Cancer Metastasis
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Brain Tumors
Ovarian Cancer
Head and Neck Cancer
Pancreatic Cancer
Liver Cancer
Bone Cancer
Cancer Stem Cells
Cancer Biomarkers
Precision Oncology
Cancer Prevention
Cancer Epidemiology
Clinical Research
Translational Oncology
Pediatric Oncology
Palliative Care
Cancer Diagnostics
Personalized Medicine
Artificial Intelligence in Oncology
Biomarker Discovery
Clinical Trials
Molecular Oncology
Emerging Cancer Therapies
Why Attend?
Whether you are an experienced oncologist or an early-career researcher, this conference offers exceptional opportunities to:
Learn from internationally recognized experts
Discover the latest cancer treatment innovations
Present research to a global audience
Meet potential collaborators
Connect with pharmaceutical and biotechnology companies
Explore future research opportunities
Strengthen academic and professional networks
Earn CME/CPD credits
Experience one of the world's leading healthcare destinations
Venue
Novotel Al Barsha, Dubai, UAE
Located in the heart of Dubai, Novotel Al Barsha provides an excellent conference environment with world-class hospitality, modern conference facilities, convenient transportation, and easy access to Dubai's major attractions. The venue offers an ideal setting for scientific exchange, networking, and international collaboration.
Who Should Attend?
The conference welcomes:
Medical Oncologists
Radiation Oncologists
Surgical Oncologists
Hematologists
Pathologists
Researchers
Scientists
Physicians
Clinical Investigators
Academicians
Professors
Students
Healthcare Professionals
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Hospital Administrators
Public Health Professionals
Policy Makers
Industry Leaders
Important Dates
Early Bird Registration Deadline: 15 July 2026
Conference Dates: 1–2 February 2027
Venue: Novotel Al Barsha, Dubai, UAE
Summary
The 13th International Cancer and Medical Oncology Conference and Exhibition represents an outstanding opportunity to share innovative research, discover the latest scientific developments, and engage with leading experts shaping the future of cancer diagnosis, treatment, and prevention. With comprehensive scientific sessions, international networking opportunities, and approximately 30 CME/CPD credits, this conference provides significant value for clinicians, researchers, and healthcare professionals alike.
Conclusion
Cancer research continues to transform healthcare through innovation and collaboration. By submitting your abstract before the 15 July 2026 Early Bird Deadline, you can become part of a global scientific community dedicated to advancing oncology and improving patient outcomes. Join us in Dubai on February 1–2, 2027, to present your research, exchange ideas, build collaborations, and contribute to the future of cancer care.
Important Links
Conference Websitehttps://cancer.ucgconferences.com/
Registrationhttps://cancer.ucgconferences.com/registration
Abstract Submissionhttps://cancer.ucgconferences.com/submit-abstract
Cancer Conference 2027, Oncology Conference Dubai, Cancer Research Conference, Medical Oncology Conference, Call for Abstracts, Cancer Abstract Submission, Oncology Meeting UAE, International Cancer Conference, Cancer Research Summit, Oncology Congress 2027, Cancer Scientists Conference, Clinical Oncology Conference, Precision Oncology, Immunotherapy Conference, Radiotherapy Conference, Cancer Diagnostics, Cancer Prevention, Translational Oncology, Molecular Oncology, Cancer Biomarkers, Breast Cancer Conference, Lung Cancer Research, Clinical Cancer Research, Cancer Education, Cancer Innovation, Cancer Therapy Conference, Oncology Networking, CME Oncology Conference, CPD Cancer Conference, Cancer Symposium Dubai, Oncology Exhibition, Cancer Clinical Trials, Cancer Genetics Conference, Tumor Microenvironment, Oncology Experts Meeting, Cancer Healthcare Conference, Medical Research Conference, Oncology Researchers, Cancer Medicine Conference, UCG Cancer Conference.
#CancerConference #OncologyConference #CancerResearch #MedicalOncology #CancerCare #CancerTreatment #ClinicalResearch #CancerScientists #CancerInnovation #PrecisionOncology #Immunotherapy #Radiotherapy #Chemotherapy #SurgicalOncology #BreastCancer #LungCancer #ColorectalCancer #ProstateCancer #CancerGenetics #CancerBiomarkers #CancerPrevention #CancerAwareness #TumorBiology #CancerMedicine #HealthcareInnovation #MedicalResearch #ClinicalTrials #CancerEducation #DubaiConference #CME #CPD #HealthcareProfessionals #OncologyResearch #GlobalHealthcare #CancerExperts #BiomedicalResearch #CancerNetworking #MedicalConference #UCGConferences #Cancer2027
